Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Nature
|
March 27, 1997
Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease
D F Emerich, S R Winn, P M Hantraye, et al.
Cell Transplantation
|
January 1, 1995
Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases
J P Hammang, D F Emerich, S R Winn, et al.
Experimental Neurology
|
March 1, 1995
Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms
M D Lindner, S R Winn, E E Baetge, et al.
Experimental Neurology
|
May 1, 1997
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats
M D Lindner, M A Plone, T D Mullins, et al.
Restorative Neurology and Neuroscience
|
May 10, 2011
Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats
M D Lindner, M A Plone, B Frydel, et al.
Cell Transplantation
|
October 23, 1997
Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates
T Subramanian, D F Emerich, R A Bakay, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Nature
|
March 27, 1997
Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease
D F Emerich, S R Winn, P M Hantraye, et al.
Cell Transplantation
|
January 1, 1995
Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases
J P Hammang, D F Emerich, S R Winn, et al.
Experimental Neurology
|
March 1, 1995
Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms
M D Lindner, S R Winn, E E Baetge, et al.
Experimental Neurology
|
May 1, 1997
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats
M D Lindner, M A Plone, T D Mullins, et al.
Restorative Neurology and Neuroscience
|
May 10, 2011
Intraventricular encapsulated calf adrenal chromaffin cells: viable for at least 500 days in vivo without detectable adverse effects on behavioral/cognitive function or host immune sensitization in rats
M D Lindner, M A Plone, B Frydel, et al.
Cell Transplantation
|
October 23, 1997
Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates
T Subramanian, D F Emerich, R A Bakay, et al.
Page
of 6